Work

Preliminary results from a phase II study of the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in patients > 70 years of age with previously untreated advanced non-small cell lung carcinoma

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.7080

Authors: B. E. Johnson, J. Lucca, M. S. Rabin, T. J. Lynch, P. Ostler, A. T. Skarin, J. Temel, G. Liu, P. A. Janne

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2595234007

Cites:

Cited by: 27

Related to: 10